Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Merck challenges Gilead with $3.85B hepatitis C acquisition

 

Merck challenges Gilead with $3.85B hepatitis C acquisition

2014-06-10 05:02:20| Biotech - Topix.net

Merck will spend about $3.85 billion for Idenix Pharmaceuticals, a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions.

Tags: challenges acquisition hepatitis merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

28.09 Tropical Storm Joyce Public Advisory Number 5 28.09 Summary for Tropical Storm Joyce (AT1/AL112024) 28.09 Post-Tropical Cyclone Helene Public Advisory Number 21 28.09 Tropical Storm Joyce Forecast Discussion Number 5 28.09 Tropical Storm Joyce Wind Speed Probabilities Number 5 28.09 Tropical Storm Joyce Forecast Advisory Number 5 28.09 Hurricane Isaac Graphics 28.09 Hurricane Isaac Forecast Discussion Number 11 More »